Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
12.70
-0.71 (-5.29%)
At close: Mar 13, 2026, 4:00 PM EDT
12.53
-0.17 (-1.34%)
After-hours: Mar 13, 2026, 5:51 PM EDT

Enanta Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
-71.54-81.89-116.05-133.82-121.76-79
Depreciation & Amortization
4.934.592.342.372.973.33
Stock-Based Compensation
16.7118.5726.828.2226.9720.99
Other Adjustments
-1.14-0.441.02-7.950.24-1.64
Change in Receivables
-0.78-0.241.9711.73.26-0.08
Changes in Accounts Payable
-1.21-1.31-0.41-1.15-4.633.77
Changes in Accrued Expenses
-2.210.06-5.65-2.56-1.488.35
Changes in Other Operating Activities
41.141.411.220.039.64-25.73
Operating Cash Flow
-14.17-19.27-78.76-103.15-84.78-70
Capital Expenditures
-4.29-12.9-17.95-9.06-2.13-0.75
Purchases of Investments
-358.25-209.63-307.28-373.39-171.45-307.35
Proceeds from Sale of Investments
286.69262.87383.47328.87228.47345.09
Investing Cash Flow
-75.8540.3558.24-53.5854.936.99
Long-Term Debt Issued
---200--
Long-Term Debt Repaid
-27.4-26.49-27.48---
Net Long-Term Debt Issued (Repaid)
-27.4-26.49-27.48200--
Issuance of Common Stock
70.210.150.152.2121.263.61
Repurchase of Common Stock
-0.24-0.28-0.29-3.76-1.23-0.53
Net Common Stock Issued (Repurchased)
69.98-0.13-0.15-1.5520.033.08
Other Financing Activities
----0.33--
Financing Cash Flow
42.5-26.62-27.63198.1320.033.08
Net Cash Flow
-47.52-5.54-48.1641.39-9.85-29.93
Free Cash Flow
-18.46-32.17-96.71-112.21-86.91-70.75
FCF Margin
-27.57%-49.24%-142.99%-141.67%-100.87%-72.88%
Free Cash Flow Per Share
-0.80-1.51-4.57-5.35-4.22-3.51
Levered Free Cash Flow
-60.61-76.54-153.9755.82-117.38-90.02
Unlevered Free Cash Flow
-33.51-51.82-130.34-150.53-119.03-91.48
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q